Publications by authors named "Lu-kui Chen"

Our previous study demonstrated the potential therapeutic role of human neural stem cell-derived exosomes (hNSC-Exo) in ischemic stroke. Here, we loaded brain-derived neurotrophic factor (BDNF) into exosomes derived from NSCs to construct engineered exosomes (BDNF-hNSC-Exo) and compared their effects with those of hNSC-Exo on ischemic stroke both in vitro and in vivo. In a model of HO-induced oxidative stress in NSCs, BDNF-hNSC-Exo markedly enhanced cell survival.

View Article and Find Full Text PDF

Objective: Glioblastoma (GB) is a refractory malignancy with a high rate of recurrence and treatment resistance. Hypoxia-related genes are promising prognostic indicators for GB, so we herein developed a reliable hypoxia-related gene risk scoring model to predict the prognosis of patients with GB.

Method: Gene expression profiles and corresponding clinicopathological features of patients with GB were obtained from the Cancer Genome Atlas (TCGA; n = 160) and Gene Expression Omnibus (GEO) GSE7696 (n = 80) databases.

View Article and Find Full Text PDF

Previous research found that cerebral dopamine neurotrophic factor (CDNF) has a protective effect on brain dopaminergic neurons, and CDNF is regarded as a promising therapeutic agent for neurodegenerative diseases. However, the effects of CDNF on the proliferation, differentiation, and apoptosis of neural stem cells (NSCs), which are very sensitive to hypoxic environments, remain unknown. In this study, NSCs were extracted from the hippocampi of fetal rats and cultured with different concentrations of CDNF.

View Article and Find Full Text PDF

Gliomas are a group of heterogeneous primary central nervous system tumors arising from glial cells. These tumors are associated with high morbidity and mortality. New opportunities for the development of effective therapies for malignant gliomas are urgently needed.

View Article and Find Full Text PDF

Objective: To explore the methods and techniques of repairing cerebrospinal fluid (CSF) rhinorrhea and reconstructing the defects of skull base under endoscopy.

Methods: The clinical data of 26 patients undergoing endoscopic repair of CSF rhinorrhea were analyzed retrospectively. There were 19 males and 7 females with an average age of 31.

View Article and Find Full Text PDF
Article Synopsis
  • A study using a glioblastoma model in nude mice tested the effects of two monoclonal antibodies, DC101 (targeting VEGFR-2) and C225 (targeting EGFR), alone and in combination.
  • DC101 treatment alone significantly reduced tumor volume and microvessel density while increasing tumor cell apoptosis, although it also led to increased tumor invasiveness.
  • The combination therapy of DC101 and C225 showed improved tumor control by reducing tumor volume, microvessel density, and proliferation while promoting apoptosis and reducing invasiveness compared to individual treatments.
View Article and Find Full Text PDF